Javascript must be enabled to continue!
Exploration of O-GlcNAc-transferase (OGT) glycosylation sites reveals a target sequence compositional bias
View through CrossRef
AbstractO-GlcNAc transferase (OGT) is an essential glycosylating enzyme that catalyzes the addition of N-acetylglucosamine to serine or threonine residues of nuclear and cytoplasmic proteins. The enzyme glycosylates a broad range of peptide sequences and prediction of glycosylation sites has proven challenging. The lack of an experimentally verified set of polypeptide sequences that are not glycosylated by OGT has made prediction of legitimate glycosylation sites more difficult. Here, we tested a number of intrinsically disordered protein regions as substrates of OGT to establish a set of sequences that are not glycosylated by OGT. The negative data set suggests an amino acid compositional bias for OGT targets. This compositional bias was validated by modifying the amino acid composition of the protein Fused in sarcoma (FUS) to enhance glycosylation. NMR experiments demonstrate that the tetratricopeptide repeat (TPR) region of OGT can bind FUS and that glycosylation-promoting mutations enhance binding. These results provide evidence that the TPR recognizes disordered segments of substrates with particular compositions to promote glycosylation, providing insight into the broad specificity of OGT.
Cold Spring Harbor Laboratory
Title: Exploration of O-GlcNAc-transferase (OGT) glycosylation sites reveals a target sequence compositional bias
Description:
AbstractO-GlcNAc transferase (OGT) is an essential glycosylating enzyme that catalyzes the addition of N-acetylglucosamine to serine or threonine residues of nuclear and cytoplasmic proteins.
The enzyme glycosylates a broad range of peptide sequences and prediction of glycosylation sites has proven challenging.
The lack of an experimentally verified set of polypeptide sequences that are not glycosylated by OGT has made prediction of legitimate glycosylation sites more difficult.
Here, we tested a number of intrinsically disordered protein regions as substrates of OGT to establish a set of sequences that are not glycosylated by OGT.
The negative data set suggests an amino acid compositional bias for OGT targets.
This compositional bias was validated by modifying the amino acid composition of the protein Fused in sarcoma (FUS) to enhance glycosylation.
NMR experiments demonstrate that the tetratricopeptide repeat (TPR) region of OGT can bind FUS and that glycosylation-promoting mutations enhance binding.
These results provide evidence that the TPR recognizes disordered segments of substrates with particular compositions to promote glycosylation, providing insight into the broad specificity of OGT.
Related Results
Regulation of O-GlcNAc Transferase in breast cancer and its role in regulating lipid metabolism
Regulation of O-GlcNAc Transferase in breast cancer and its role in regulating lipid metabolism
Cancer cells exhibit altered metabolism characterized by increased glucose and glutamine uptake. Altered utilization of these substrates directly contributes to O-linked-[beta]-N-a...
Ogt-mediated O-GlcNAcylation inhibits astrocytes activation through modulating NF-κB signaling pathway
Ogt-mediated O-GlcNAcylation inhibits astrocytes activation through modulating NF-κB signaling pathway
AbstractPrevious studies have shown that Ogt-mediated O-GlcNAcylation is essential for neuronal development and function. However, the function of O-GlcNAc transferase (Ogt) and O-...
SFSWAP is a negative regulator of OGT intron detention and global pre-mRNA splicing
SFSWAP is a negative regulator of OGT intron detention and global pre-mRNA splicing
Abstract
O-GlcNAcylation is the reversible post-translational addition of β-N-acetylglucosamine to serine and threonine residues of nuclear and cytoplasmic proteins. It plays an im...
The role of KLF8 in breast cancer stem cells
The role of KLF8 in breast cancer stem cells
Breast tumors are comprised of heterogenous cell populations. This intra-tumor heterogeneity drives tumor-initiation, metastasis, and resistance to anti-cancer treatments, potentia...
A glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients
A glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients
Abstract
Early detection of Alzheimer’s disease is vital for timely treatment. Existing biomarkers for Alzheimer’s disease reflect amyloid- and tau-related pathology...
Arginine glycosylation regulates UDP-GlcNAc biosynthesis in Salmonella enterica
Arginine glycosylation regulates UDP-GlcNAc biosynthesis in Salmonella enterica
AbstractThe Salmonella enterica SseK1 protein is a type three secretion system effector that glycosylates host proteins during infection on specific arginine residues with N-acetyl...
Application value of overlap guiding tube (OGT) in assisting overlap esophagojejunostomy during laparoscopic total gastrectomy for gastric/gastroesophageal junction (G/GEJ) tumors
Application value of overlap guiding tube (OGT) in assisting overlap esophagojejunostomy during laparoscopic total gastrectomy for gastric/gastroesophageal junction (G/GEJ) tumors
Abstract
Background
The overlap guiding tube (OGT) method, which was designed by our team to assist in overlap esophagojejunostomy, could potentiall...
Innovative Metrics for Reporting and Comparing the Glycan Structural Profile in Biotherapeutics
Innovative Metrics for Reporting and Comparing the Glycan Structural Profile in Biotherapeutics
Glycosylation is a critical quality attribute in biotherapeutics, impacting properties such as protein stability, solubility, clearance rate, efficacy, immunogenicity, and safety. ...

